Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
We evaluate your BMI, medical history, and risk factors before prescribing
The STEP 1 trial showed participants lost an average of 14.9% of their body weight over 68 weeks at the 2.4mg dose
Zepbound (tirzepatide): This week's injectable treatment works by targeting GLP-1 and GIP receptors, offering the utmost weight loss efficiency recorded in clinical trials
The FIB-4 index, calculated from age, platelet count, and transaminase levels, provides a simple screening tool for advanced fibrosis
To further investigate the bill and see the full legislation that passed the Senate, please check out some of our other resources
If you are responding well glycemically on tirzepatide, the incremental benefit of switching is less clear than for pure weight loss goals
US$ 26.56
US$ 20.81
US$ 29.68
US$ 28.43
